Rapid Self-healing Gel Market Analysis

Rapid Self-healing Gel Market Analysis

Rapid self-healing gel market for physical crosslinking segment constituted more than 60% of the total industry share in 2018 and is anticipated to witness gains close to 7% in the forecast timeframe. In physical crosslinking, rapid self-healing gels are highly stable in the presence of 3D network, in which the polymer chains are linked by stable covalent bonds.

Some of the examples of physical crosslinking-based product are xanthan–glucomannan, PEG-polyester copolymers or poly(N-isopropylacrylamide) (pNIPAAm), among several others. These gels exhibit excellent mechanical, self-healing and ionic conductive properties.

In terms of volume, wound healing segment constituted approximately 45% of the total industry share in 2018. The gels are widely applicable in wound dressing or healing owing to its excellent properties which includes high sensitivity to physiological environments, hydrophilic nature, soft tissue-like water content and adequate flexibility, which makes them excellent entrants for biomedical applications.
 

For instance, the global population base pertaining to the age group 60 years was 841 million in 2014 and is projected to reach 2 billion in 2050. The people in this age group are expected to experience a growth in the occurrence of chronic wounds such as venous stasis ulcers and pressure ulcers, which will have significant positive impact on the product demand, thereby driving the rapid self-healing gel market growth in the forecast timeframe.
 

In 2018, Asia Pacific constituted approximately 15% of the total industry size and is likely to rise at CAGR close to 7.5% in the forecast period. High investment in R&D and demand surge for specialty medical products in the pharmaceutical & healthcare industry will have a notable impact on the product demand and thus trigger the rapid self-healing gel market in the region in the foreseeable future.
 

Furthermore, rapidly growing population and unavailability of efficient pharmaceutical facilities in the region will drive the market growth by 2025.